Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese medicine composition for treating mycoplasma gallisepticum infection

A technology of mycoplasma gallisepticum and composition, applied in antibacterial drugs, pharmaceutical formulations, plant raw materials, etc., can solve the problems of antibiotic abuse, bacterial drug resistance, and increased operating costs of chicken farms, achieving no drug residues, Improve the body's immunity and have no side effects

Inactive Publication Date: 2014-12-31
RINGPU TIANJIN BIOLOGICAL PHARMA
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, some antibiotics that have inhibitory effect on viral mycoplasma are mainly used for treatment in China. Regardless of drinking water or feed mixing, they have to be used for several days. Due to the extensive use of antibiotics, the operating cost of the chicken farm has increased, and it is easy to cause the abuse of antibiotics. , resulting in the development of drug-resistant bacteria in chickens

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for treating mycoplasma gallisepticum infection
  • Traditional Chinese medicine composition for treating mycoplasma gallisepticum infection
  • Traditional Chinese medicine composition for treating mycoplasma gallisepticum infection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015]

Embodiment 2

[0017]

Embodiment 3

[0019]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating mycoplasma gallisepticum infection. The composition consists of honeysuckle, forsythia, bupleurum root, folium isatidis, radix scutellariae, bulbus fritillariae cirrhosae and peppermint oil. Clinical tests prove that the composition can effectively treat chicken runny nose, fever, cough, asthma, dry and wet rales, bloody mucus caused by coughs, loss of appetite, lethargy, eye closure and other symptoms.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for clearing, detoxifying, treating mycoplasma gallisepticum infection and enhancing body immunity. Background technique [0002] Mycoplasma gallisepticum infection is prevalent in chicken farms all over the world, especially in China. The disease mainly occurs in chicks aged 1-2 months, and it is more prone to epidemics in chicken farms with large breeding volume and high density. [0003] The most common symptoms of Mycoplasma gallisepticum infection are respiratory symptoms, mainly coughing, sneezing, tracheal rales and rhinitis. Changes in the respiratory tract also vary in severity. Slight and imperceptible, more viscous fluid or catarrhal secretions appear in the nostrils, sinuses, trachea and lungs, and the tracheal wall is slightly edematous. As the infection progresses, the air sacs gradually become turbid, and a cheese-like exudate appears on the walls of the air sacs, bea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8966A61P31/04
Inventor 付春香孙俊徐晓然
Owner RINGPU TIANJIN BIOLOGICAL PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products